검색어: valsartana (크로아티아어 - 영어)

poluvijek valsartana je 6 sati.
the half-life of valsartan is 6 hours.

jedna tableta sadrži 10 mg amlodipina i 160 mg valsartana.
each tablet contains 10 mg amlodipine and 160 mg valsartan.

ne postoje klinička ispitivanja djelovanja amlodipina/valsartana na plodnost.
there are no clinical studies on fertility with amlodipine/valsartan.

nisu dostupne informacije o primjeni valsartana i/ili amlodipina tijekom dojenja.
no information is available regarding the use of valsartan and/or amlodipine during breast-feeding.

utvrđen je hidroksilni metabolit valsartana u plazmi pri niskim koncentracijama (<10%).
a hydroxyl metabolite of valsartan has been identified in plasma at low concentrations (<10%).

kod terapijskih doza valsartana u ljudi čini se da hipertrofija jukstaglomerularnih bubrežnih stanica nema nikakav značaj.
for therapeutic doses of valsartan in humans, the hypertrophy of the renal juxtaglomerular cells does not seem to have any relevance.

jedna tableta sadrži 10 mg amlodipina (u obliku amlodipinbesilata) i 160 mg valsartana.
each tablet contains 10 mg amlodipine (as amlodipine besilate) and 160 mg valsartan.

brzina i opseg apsorpcije copalie jednaki su bioraspoloživosti valsartana i amlodipina kada se primjenjuju kao pojedinačne tablete.
the rate and extent of absorption of copalia are equivalent to the bioavailability of valsartan and amlodipine when administered as individual tablets.

u bolesnika s blagim do umjerenim oštećenjem jetre, bez kolestaze, najviša preporučena doza valsartana je 80 mg.
in patients with mild to moderate hepatic impairment without cholestasis, the maximum recommended dose is 80 mg valsartan.

jedna filmom obložena tableta sadrži 10 mg amlodipina (u obliku amlodipinbesilata) i 160 mg valsartana.
each film-coated tablet contains 10 mg of amlodipine (as amlodipine besilate) and 160 mg of valsartan.

jedna tableta sadrži 10 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 25 mg hidroklorotiazida.
each tablet contains 10 mg amlodipine (as amlodipine besylate), 160 mg valsartan and 25 mg hydrochlorothiazide.

apsorpcija: nakon peroralne primjene samo valsartana, vršne koncentracije valsartana u plazmi postižu se u 2–4 sata.
absorption: following oral administration of valsartan alone, peak plasma concentrations of valsartan are reached in 2–4 hours.

svaka filmom obložena tableta sadrži 10 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 25 mg hidroklorotiazida.
each film-coated tablet contains 10 mg amlodipine (as amlodipine besylate), 160 mg valsartan, and 25 mg hydrochlorothiazide.

nakon peroralne primjene amlodipina/valsartana, vršne koncentracije amlodipina i valsartana u plazmi postižu se u 3 odnosno 6–8 sati.
following oral administration of amlodipine/valsartan, peak plasma concentrations of valsartan and amlodipine are reached in 3 and 6–8 hours, respectively.

146 mg sakubitrila/154 mg valsartana/kg/dan tijekom 39 tjedana, nije bilo dokaza prisutnosti amiloidnih plakova u mozgu.
146 mg sacubitril/154 mg valsartan/kg/day for 39 weeks, there was no evidence for the presence of amyloid plaques in the brain.

svaka filmom obložena tableta sadrži 24,3 mg sakubitrila i 25,7 mg valsartana (u obliku sakubitril valsartan kompleksa natrijeve soli).
each film-coated tablet contains 24.3 mg sacubitril and 25.7 mg valsartan (as sacubitril valsartan sodium salt complex).

nužan je oprez kod primjene amlodipina/valsartana bolesnicima s oštećenjem jetre ili opstruktivnim bolestima žučnog sustava (vidjeti dio 4.4).
caution should be exercised when administering amlodipine/valsartan to patients with hepatic impairment or biliary obstructive disorders (see section 4.4).

svaka tableta od 24 mg/26 mg sadrži 24,3 mg sakubitrila i 25,7 mg valsartana (u obliku sakubitril valsartan kompleksa natrijeve soli).
each 24 mg/26 mg tablet contains 24.3 mg sacubitril and 25.7 mg valsartan (as sacubitril valsartan sodium salt complex).

dapagliflozin: dapagliflozin nije značajno izmijenio farmakokinetiku saksagliptina, metformina, pioglitazona, sitagliptina, glimepirida, voglibosa, hidroklorotiazida, bumetanida, valsartana ni simvastatina.
dapagliflozin: dapagliflozin did not meaningfully alter the pharmacokinetics of saxagliptin, metformin, pioglitazone, sitagliptin, glimepiride, voglibose, hydrochlorothiazide, bumetanide, valsartan, or simvastatin.

amlodipin/valsartan mylan dostupan je u obliku tableta (5 mg amlodipina i 80 mg valsartana; 5 mg amlodipina i 160 mg valsartana; 10 mg amlodipina i 160 mg valsartana).
amlodipine/valsartan mylan is available as tablets (5 mg amlodipine and 80 mg valsartan; 5 mg amlodipine and 160 mg valsartan; 10 mg amlodipine and 160 mg valsartan).